Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Emerging Market for Clinical Trials in Argentina Major Cost Advantages over the US in Conducting Clinical Trials Will Encourage Drug Development |
Jul 2011 | £2,215 | 100% |
| Emerging Market for Clinical Trials in Russia Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player |
Jul 2011 | £2,215 | 98% |
| Emerging Clinical Trial Locations - India Market Dynamics and The Changing Healthcare and Regulatory Environment |
Jun 2009 | £2,425 | 98% |
| Emerging Clinical Trial Locations - China Market Dynamics and The Changing Healthcare and Regulatory Environment |
Jun 2009 | £2,425 | 98% |
| Emerging Clinical Trial Locations -Latin America Market Dynamics and The Changing Healthcare and Regulatory Environment |
Jun 2009 | £2,425 | 97% |
| Emerging Clinical Trial Locations - Eastern Europe Market Dynamics and The Changing Healthcare and Regulatory Environment |
Jun 2009 | £2,425 | 97% |
| Conducting Clinical Trials in Europe An Insider's Analysis |
Dec 2008 | £2,370 | 97% |
| Emerging Market for Clinical Trials in Poland Cost Advantages of Nearly 30% as Compared to the US |
Dec 2011 | £2,215 | 96% |
| Emerging Market for Clinical Trials in China Communication Problems and Unresolved Intellectual Property Issues Restrict Growth |
Apr 2011 | £2,215 | 96% |
| Emerging Markets for Clinical Trials in India Favorable Regulatory Environment and Cost Effectiveness Will Accelerate the Number of Clinical Trials |
Jan 2011 | £2,215 | 95% |
| Emerging Market for Clinical Trials in Brazil Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market |
Jul 2011 | £2,215 | 95% |
| Booming Clinical Trials Market in India | Aug 2011 | £630 | 90% |
| Clinical Trials: World Market 2010-2025 |
Jul 2010 | £1,499 | 90% |
| Clinical Trials Market - India | Jul 2009 | £240 | 87% |
| Typhoid Fever Global Clinical Trials Review H2, 2011 |
Nov 2011 | £630 | 87% |
| Drug Targets for Breast Cancer | Jan 2006 | £1,095 | 87% |
| Industry Insight Clinical Trials in India 2007 | May 2007 | £400 | 86% |
| Clinical Trials in India | Feb 2010 | £650 | 86% |
| Point of Care Testing Evaluating The Return to Evidence Based Medicine, Novel Technologies and The Competitive Landscape |
Jan 2010 | £2,425 | 86% |
| Ventricular Fibrillation Global Clinical Trials Review Q2, 2011 |
May 2011 | £630 | 86% |
| Migraine Global Clinical Trials Review H2 2011 |
Oct 2011 | £630 | 85% |
| Emerging Pharmaceutical Market in India Strategic Partnerships between Domestic and International Pharmaceutical Players Are The Driving Force |
Aug 2011 | £2,215 | 85% |
| Clinical Trials Market in Russia | May 2011 | £630 | 85% |
| Anthrax Global Clinical Trials Review Q1, 2011 |
Mar 2011 | £630 | 84% |
| CNS Clinical Trials World Market Prospects 2011-2026 |
Dec 2010 | £1,499 | 83% |
| Global Clinical Trial Business Report & Analysis 20082018 | Jul 2008 | £1,499 | 83% |
| Trends in Clinical Trials: Strategies to Enhance Clinical Trial Design | Sep 2008 | £2,405 | 83% |
| Biobanking: Technologies and Global Markets | Jun 2011 | £3,065 | 83% |
| Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review H2, 2011 |
Aug 2011 | £630 | 83% |
| Cancer Vaccines & Circulating Tumor Cells (CTCs) 2011 Report |
Jan 2011 | £1,680 | 82% |
